Used in the pharmaceutical industry as a key intermediate in the synthesis of bioactive molecules, particularly in the development of central nervous system (CNS) drugs. Its structure is valuable for creating compounds targeting neurological disorders such as depression, anxiety, and schizophrenia. The presence of fluorine and trifluoromethyl groups enhances the molecule's ability to interact with biological targets, improving drug efficacy and metabolic stability. Additionally, it is employed in research to explore new therapeutic agents with improved selectivity and reduced side effects.